These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7536301)

  • 1. Idiopathic dilated cardiomyopathy.
    Legha SS
    N Engl J Med; 1995 May; 332(20):1385; author reply 1385-6. PubMed ID: 7536301
    [No Abstract]   [Full Text] [Related]  

  • 2. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
    Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
    Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Doxorubicin-induced cardiomyopathy].
    Czarnecki A
    Pol Tyg Lek; 1983 Apr; 38(15):471-3. PubMed ID: 6356084
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
    Hadar A; Sheiner E; Press F; Katz A; Katz M
    J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adriamycin cardiomyopathy].
    Nilles M; Wehr M; Köhler F
    Med Welt; 1984 Jan; 35(4):103-8. PubMed ID: 6700420
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma endothelin-1 and doxorubicin cardiotoxicity.
    Yamashita J; Ogawa M; Nomura K
    N Engl J Med; 1994 Dec; 331(22):1528-9. PubMed ID: 7969316
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant.
    Briec F; Delaire C; Bouhour JB; Trochu JN
    Arch Mal Coeur Vaiss; 2006 Oct; 99(10):933-5. PubMed ID: 17100146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of cardiac resynchronization therapy in the management of Doxorubicin-induced cardiomyopathy.
    Ajijola OA; Nandigam KV; Chabner BA; Orencole M; Dec GW; Ruskin JN; Singh JP
    Am J Cardiol; 2008 May; 101(9):1371-2. PubMed ID: 18435975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of heart muscle disease.
    Lewis W; Papoian T
    West J Med; 1991 Jan; 154(1):91. PubMed ID: 2024517
    [No Abstract]   [Full Text] [Related]  

  • 10. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
    Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiological monitoring of patients treated with doxorubicin].
    Mahaux V; Demoulin JC; Closon MT; Jardon-Jeghers C; Vivario M; Kulbertus H
    Rev Med Liege; 1988 Jun; 43(12):449-55. PubMed ID: 3041526
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic-induced cardiomyopathy.
    Board J
    Anaesth Intensive Care; 1986 May; 14(2):210. PubMed ID: 3740398
    [No Abstract]   [Full Text] [Related]  

  • 13. Case presentation of doxorubicin-induced cardiomyopathy: a short- and long-term side effect of pediatric cancer treatment.
    Dunn J
    J Pediatr Oncol Nurs; 1991 Apr; 8(2):84. PubMed ID: 1675089
    [No Abstract]   [Full Text] [Related]  

  • 14. Adriamycin: review of clinical pharmacology and toxicity of an effective anticancer drug.
    Riggs CE; Sharp SA
    Iowa Med; 1987 May; 77(5):242, 245-51. PubMed ID: 3298138
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiotoxic effect of adriamycin].
    Shkhvatsabaia LV; Valvere VIu; Nekliudova VI
    Kardiologiia; 1988 Apr; 28(4):110-4. PubMed ID: 3292809
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug overdose--a hidden hazard of obesity.
    Cox J; Penn N; Masood M; Hancock AK; Parker D
    J R Soc Med; 1987 Nov; 80(11):708-9. PubMed ID: 3694619
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group.
    Charron P; Tesson F; Poirier O; Nicaud V; Peuchmaurd M; Tiret L; Cambien F; Amouyel P; Dubourg O; Bouhour J; Millaire A; Juilliere Y; Bareiss P; André-Fouët X; Pouillart F; Arveiler D; Ferrières J; Dorent R; Roizès G; Schwartz K; Desnos M; Komajda M
    Eur Heart J; 1999 Nov; 20(21):1587-91. PubMed ID: 10529327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy: how to buy time.
    Luquire R; Houston S
    RN; 1993 May; 56(5):28-33. PubMed ID: 8327840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dilated cardiomyopathy in a user of anabolic steroids].
    Schollert PV; Bendixen PM
    Ugeskr Laeger; 1993 Apr; 155(16):1217-8. PubMed ID: 8497958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy.
    Fauchier L; Babuty D; Poret P; Casset-Senon D; Autret ML; Cosnay P; Fauchier JP
    Eur Heart J; 2000 Feb; 21(4):306-14. PubMed ID: 10653678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.